Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells

BACKGROUND: The use of glucose as the only osmotic agent in peritoneal dialysis (PD) solutions (PDSs) is believed to exert local (peritoneal) and systemic detrimental actions, particularly in diabetic PD patients. To improve peritoneal biocompatibility, we have developed more biocompatible PDSs cont...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drug Des Devel Ther
Main Authors: Bonomini, Mario, Di Silvestre, Sara, Di Tomo, Pamela, Di Pietro, Natalia, Mandatori, Domitilla, Di Liberato, Lorenzo, Sirolli, Vittorio, Chiarelli, Francesco, Indiveri, Cesare, Pandolfi, Assunta, Arduini, Arduino
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135076/
https://ncbi.nlm.nih.gov/pubmed/27932866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S117078
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki